All News
Filter News
Found 808,966 articles
-
Virtual Incision’s Miniaturized Robotic-Assisted Surgery Device Will Launch into Space in 2024
8/2/2022
Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery platform, announced that its MIRA™ Platform will test its skills in space on a 2024 technology demonstration mission aboard the International Space Station.
-
Geno Hires First Chief Legal Officer on Path to Accelerate the Transition to More Sustainable Materials
8/2/2022
Sustainability leader Genomatica welcomes its first chief legal officer Shawnte Mitchell to help fuel the company's rapid growth.
-
NeuroSense Joins EverythingALS Open Innovation Consortium; Set to Enroll US and EU Patients in Phase IIb Study
8/2/2022
EverythingALS, today announced NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, as a new collaborator in the effort to identify treatments and a cure for ALS.
-
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 02, 2022
8/2/2022
Astria Therapeutics, Inc., a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, granted equity awards on August 1, 2022 under Astria’s 2022 Inducement Stock Incentive Plan.
-
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
8/2/2022
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2.
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 02, 2022
8/2/2022
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that the Company granted non-statutory stock options to new employees as inducement awards outside of the Company’s 2019 Stock Incentive Plan.
-
ŌNŌCOR Reports First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Intracardiac TumorUntil now, removal of intracardiac tumors has typically required open-heart surgery
8/2/2022
ŌNŌCOR LLC is excited to announce the first-in-human use of the ŌNŌ endovascular retrieval system for removal of an intracardiac tumor. Intracardiac tumors affect thousands of patients around the world annually, but prior to ŌNŌ, open-heart surgery was required for removal.
-
Frontage Laboratories Inc. Acquires Frontage Clinical Services Inc.
8/2/2022
Frontage Laboratories, Inc. completed the acquisition of Frontage Clinical Services Inc., a clinical Phase I-IIa business located in Secaucus, NJ. Frontage Clinical provides a complete suite of services from study design to the delivery of final reports.
-
Light E.N.T. Seeks Volunteers for ENLIGHTEN I Phase 3 Clinical Research Study in Chronic Rhinosinusitis
8/2/2022
Light E.N.T. is seeking volunteers for Phase 3 of the ENLIGHTEN I clinical research study.
-
Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer
8/2/2022
Xenetic Biosciences, Inc. today announced a research and development collaboration to develop Neutrophil Extracellular Traps targeted, adoptive cell therapies for the treatment of cancer.
-
Summit Therapeutics’ Rights Offering Nearing Expiration Date
8/2/2022
Summit Therapeutics Inc. announced that it is nearing the previously-announced expiration date for its rights offering of 5:00 pm Eastern Daylight Time on August 8, 2022.
-
VBL Therapeutics Announces Workforce Reduction
8/2/2022
VBL Therapeutics, a biotechnology company developing targeted medicines for cancer and immune-inflammatory diseases, announced an organizational streamlining designed to reduce operating expenses and preserve capital.
-
Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis
8/2/2022
Agilent Technologies Inc. (NYSE: A) today announced it has acquired Polymer Standards Service GmbH (PSS), a provider of solutions in the field of polymer characterization. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures.
-
Surgery Partners, Inc. Announces Second Quarter 2022 Results
8/2/2022
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter ended June 30, 2022.
-
Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development
8/2/2022
Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that neonatologist and breastfeeding advocate Erin Hamilton Spence, MD, IBCLC, has been appointed director of clinical education and professional development.
-
Sironax Announces Closing of $200 Million Series B Financing
8/2/2022
Sironax today announced the completion of a $200 million Series B financing.
-
Oxford-Harrington Rare Disease Centre to Advance Novel Treatment for Duchenne Muscular Dystrophy
8/2/2022
The Oxford-Harrington Rare Disease Centre (OHC), a partnership of the University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced its support of a novel treatment for Duchenne muscular dystrophy, a rare neuromuscular disease characterized by progressive muscle degeneration and weakness.
-
STRATA Skin Sciences Announces Upcoming KOL Call Hosted by Ladenburg Thalmann
8/2/2022
STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the Company’s XTRAC Excimer Laser will be highlighted in an upcoming Key Opinion Leader Call hosted by Ladenburg Thalmann.
-
Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
8/2/2022
Day One Biopharmaceuticals announced that management will participate in a panel discussion at the 2022 Wedbush PacGrow Healthcare Virtual Conference.
-
Nordson Corporation Announces Earnings Release and Webcast for Third Quarter Fiscal Year 2022
8/2/2022
Nordson Corporation announced it will release third quarter fiscal year 2022 earnings on August 22, 2022 after the close of the market.